复杂性视网膜毛细血管瘤内切除术后治疗效果
回顾性病例系列纳入12例(13眼)复杂性视网膜毛细血管瘤患者,均行经平坦部玻璃体切除、供应与引流血管眼内透热、瘤体内切除及硅油填充。初次手术后解剖成功率为92%,末次随访视力由术前平均20/303改善至20/73,7眼(54%)视力提高、6眼(46%)稳定。作者认为该联合术式对复杂性视网膜毛细血管瘤可能为有效治疗选择。
要点
- 12例(13眼)复杂性视网膜毛细血管瘤行玻璃体切除联合眼内透热、瘤体内切除及硅油填充。
- 初次手术后解剖成功率为92%,1眼因复发性视网膜脱离行二次玻璃体视网膜手术。
- 末次随访平均视力20/73,较术前20/303改善,7眼(54%)提高、6眼(46%)稳定。
核心结论
- 联合经平坦部玻璃体切除、供应与引流血管眼内透热、视网膜毛细血管瘤内切除及硅油填充可能为复杂性视网膜毛细血管瘤的有效治疗选择,可获得高解剖成功率、稳定甚至改善的视力、可接受的疾病与治疗相关并发症发生率及极少的再治疗需求。
研究设计与样本
- 回顾性病例系列,纳入12例患者(13眼),全部接受经平坦部玻璃体切除、供应与引流血管眼内透热、视网膜毛细血管瘤内切除及硅油填充。
- 手术时平均年龄为32.5 ± 15.9岁,初次手术后平均随访时间为50.5 ± 49.4个月。
主要发现
- 手术指征包括视网膜毛细血管瘤伴牵拉性视网膜脱离5眼(38%)、渗出性视网膜脱离4眼(31%)、牵拉性与渗出性视网膜脱离并存4眼(31%)。
- 切除的视网膜毛细血管瘤尺寸为>3.0 mm 7眼(54%)、>3.5 mm 3眼(23%)、>4.0 mm 3眼(23%),无肿瘤距视神经或黄斑中心凹小于10 mm。
- 初次手术后解剖成功率为92%,1眼因复发性视网膜脱离行第二次玻璃体视网膜手术。
- 术前平均Snellen视力为20/303,末次随访平均Snellen视力为20/73;末次随访时7眼(54%)视力提高、6眼(46%)稳定。
- 短期并发症包括复发性增生性玻璃体视网膜病变1眼(8%)、需局部抗青光眼药物治疗的一过性眼压升高4眼(31%);长期并发症包括白内障进展7眼(54%)。
临床怎么用
- 作者认为,联合经平坦部玻璃体切除、供应与引流血管眼内透热、视网膜毛细血管瘤内切除及硅油填充可能为复杂性视网膜毛细血管瘤的有效治疗选择。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
PURPOSE: To evaluate the anatomical and functional outcomes after endoresection of complex retinal capillary hemangioblastoma (RCH). METHODS: Retrospective case series of 12 patients (13 eyes), all treated with pars plana vitrectomy, endodiathermy of feeding and draining vessels, endoresection of RCH and silicone oil injection. RESULTS: The mean age at the time of surgery was 32.5 ± 15.9 years. The mean follow-up duration after initial surgery was 50.5 ± 49.4 months. Indications for surgery included RCH with associated complications such as tractional retinal detachment in five eyes (38%), exudative retinal detachment in four eyes (31%), and combination of tractional retinal detachment and exudative retinal detachment in four eyes (31%). The dimensions of the resected RCHs were as follows: >3.0 mm in seven eyes (54%), >3.5 mm in three eyes (23%), and >4.0 mm in three eyes (23%). No tumor was located closer than 10 mm to the optic nerve or fovea. Anatomical success after initial surgery was 92%. One eye had a second vitreoretinal procedure owing to recurrent RD. The mean preoperative Snellen visual acuity was 20/303. The mean Snellen visual acuity at the final visit was 20/73. At the final visit, visual acuity had improved in seven eyes (54%), and six eyes (46%) were stable. Short-term complications included recurrent proliferative vitreoretinopathy in one eye (8%), transient ocular hypertension requiring topical antiglaucoma treatment in four eyes (31%), and long-term complications included progression of cataract in seven eyes (54%). CONCLUSION: Combined pars plana vitrectomy, endodiathermy of feeding and draining vessels, endoresection of RCH, and silicone oil injection may be an effective treatment option for complex RCH, achieving high anatomical success and stable or even improved visual acuity, acceptable rates of disease- and treatment-related complications, and minimal need for retreatment.
引用
- Karacorlu M, Hocaoglu M, Sayman Muslubas I, et al. THERAPEUTIC OUTCOMES AFTER ENDORESECTION OF COMPLEX RETINAL CAPILLARY HEMANGIOBLASTOMA. Retina. 2018. PMID: 28196061. doi:10.1097/IAE.0000000000001562
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。